SFHF_Silvermagazine_April_2024_Allergy_LeaderboardThe Westin Nova Scotian Wellness


Home » FDA

The controversy over the new Alzheimer’s drug

Just last week, the FDA approved a new drug for treating Alzheimer’s in the United States, Aduhelm. It is not approved in Canada yet, but there’s a storm of controversy over whether it is even effective at all, or at least in the ways intended. This week three scientists on the FDA’s independent neurological drug advisory panel resigned however, stating that the clinical trial data was flimsy at best with one scientist telling the New York Times, “This might be the worst approval decision that the FDA has made that I can remember,” Dr. Aaron Kesselheim. The independent panel had voted to reject the drug with ten “no” votes and one “uncertain” vote. The FDA doesn’t have to listen to the panel, they’re there for a secondary opinion only. Actual regulation of drugs and medical devices is made in-house by FDA scientists. The claim by the manufacturer is that the

Read More »